Shared voting power spans 3.47M depositary shares at Bicycle Therapeutics (BCYC).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Armistice Capital, LLC and Steven Boyd have filed an amended beneficial ownership report for Bicycle Therapeutics plc (BCYC), disclosing a 6.85% stake. They beneficially own 3,472,000 American Depositary Shares, representing shared voting and dispositive power. The Master Fund, managed by Armistice Capital, directly holds these securities and is entitled to dividends and sale proceeds.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.